Back to search
High Grade Malignant Neuroendocrine Carcinoma (Diagnosis)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which High Grade Malignant Neuroendocrine Carcinoma (Diagnosis) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which High Grade Malignant Neuroendocrine Carcinoma (Diagnosis) trials you may qualify forThe purpose of this clinical trial is to learn the safety and effects of the study medicine (PF-07799544) alone or in combination as a potential cancer treatmen…
To find the highest tolerable dose of IACS-6274 that can be given alone, in combination with bevacizumab and paclitaxel, or in combination with capivasertib to…
The main goal of this phase of the study is to determine if objectively assessed Physical Activity (PA) levels in advanced-cancer patients are associated with h…
This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipil…
To test the safety of and effectiveness of XmAb20717 for participants with advanced rare cancers.
This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal stu…